Insider · CIK 0001030468

BROWN JULIA R

Reports to the SEC for 5 companies · WINSTON-SALEM, NC

sec.gov

Transactions

Companies

Filings

CIK

0001030468

Forms 4 and 5

Insider transactions

41 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2018-06-07	ALBIREO PHARMA, INC.M Exercise/Conversion	Director	MExercise/Conversion	+3,333 sh	$9.00	+$30K	7,833
2018-06-07	ALBIREO PHARMA, INC.M Exercise/Conversion	Director	MExercise/Conversion	+3,000 sh	$17.05	+$51.2K	4,500
2018-06-07	ALBIREO PHARMA, INC.Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,500 sh	—	—	3,000
2018-06-07	ALBIREO PHARMA, INC.Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−3,000 sh	—	—	0
2018-06-07	ALBIREO PHARMA, INC.Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−3,333 sh	—	—	0
2018-06-07	ALBIREO PHARMA, INC.M Exercise/Conversion	Director	MExercise/Conversion	+1,500 sh	$18.54	+$27.8K	1,500
2017-06-16	ALBIREO PHARMA, INC.Stock Option (right to buy)A Award	Director	AAward	+3,000 sh	—	—	3,000
2017-01-23	ALBIREO PHARMA, INC.Stock Option (right to buy)A Award	Director	AAward	+4,500 sh	—	—	4,500
2016-02-24	ALBIREO PHARMA, INC.Stock Option (right to buy)A Award	Director	AAward	+100K sh	—	—	100,000
2015-08-14	GYREGYRE THERAPEUTICS, INC. · Redeemable Convertible NoteA Award	Director	AAward	—	—	—	—
2015-08-04	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+12.5K sh	—	—	12,500
2015-03-17	ALBIREO PHARMA, INC.Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2015-01-08	Statera Biopharma, Inc.A Award	Director	AAward	+62.5K sh	$0.30	+$18.8K	116,482
2014-12-11	GYREGYRE THERAPEUTICS, INC.A Award	Director	AAward	+10K sh	—	—	10,000
2014-10-01	Statera Biopharma, Inc.A Award	Director	AAward	+1,903 sh	$9.20	+$17.5K	2,700
2014-03-04	ALBIREO PHARMA, INC.Stock Option (right to buy)A Award	Director	AAward	−10K sh	—	—	10,000
2013-06-19	Statera Biopharma, Inc.A Award	Director	AAward	+15.9K sh	—	—	15,939
2013-06-14	Statera Biopharma, Inc.Stock Option (right to buy)A Award	Director	AAward	+35K sh	—	—	35,000
2013-06-07	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+12.5K sh	—	—	12,500
2013-05-10	GYREGYRE THERAPEUTICS, INC.P Purchase	Director	PPurchase	+6,000 sh	$5.09	+$30.5K	6,000
2013-04-22	Statera Biopharma, Inc.Stock Option (right to buy)A Award	Director	AAward	+15K sh	—	—	15,000
2013-03-05	ALBIREO PHARMA, INC.Stock Option (right to buy)A Award	Director	AAward	−5,000 sh	—	—	5,000
2012-06-07	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+7,500 sh	—	—	7,500
2012-04-24	ALBIREO PHARMA, INC.Employee Stock Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2011-06-15	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+7,500 sh	—	—	7,500
2011-05-13	GYREGYRE THERAPEUTICS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+9,100 sh	$8.70	+$79.2K	9,100
2011-05-13	GYREGYRE THERAPEUTICS, INC.S Sale	Director	SSale	−9,100 sh	$23.38	−$213K	0
2011-05-13	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−9,100 sh	—	—	3,400
2010-06-17	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+7,500 sh	—	—	7,500
2010-05-21	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	+7,307 sh	—	—	12,500
2010-05-21	GYREGYRE THERAPEUTICS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+7,307 sh	$8.70	+$63.6K	7,307
2010-05-21	GYREGYRE THERAPEUTICS, INC.S Sale	Director	SSale	−7,307 sh	$23.13	−$169K	0
2010-05-20	GYREGYRE THERAPEUTICS, INC.S Sale	Director	SSale	−5,193 sh	$22.97	−$119K	0
2010-05-20	GYREGYRE THERAPEUTICS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+5,193 sh	$8.70	+$45.2K	5,193
2010-05-20	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	+5,193 sh	—	—	19,807
2010-05-12	GYREGYRE THERAPEUTICS, INC.S Sale	Director	SSale	−7,500 sh	$23.05	−$173K	0
2009-06-17	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+7,500 sh	—	—	7,500
2009-03-17	GYREGYRE THERAPEUTICS, INC.P Purchase	Director	PPurchase	+7,500 sh	$3.03	+$22.7K	7,500
2008-07-02	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+7,500 sh	—	—	7,500
2007-12-05	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2005-06-16	TANOX INCStock OptionA Award	Director	AAward	+20K sh	—	—	20,000

Recent filings

Accepted (ET)
Jul 64
BROWN JULIA R0001209191-18-041870
SEC(opens sec.gov)
Jun 114
BROWN JULIA R0001209191-18-036906
SEC(opens sec.gov)
Jun 204
ALBIREO PHARMA, INC.0001209191-17-041057
SEC(opens sec.gov)
Jan 254
ALBIREO PHARMA, INC.0001209191-17-005548
SEC(opens sec.gov)
Mar 84
Biodel Inc0001145443-16-001603
SEC(opens sec.gov)
Aug 184
TARGACEPT INC0000899243-15-003396
SEC(opens sec.gov)
Aug 54
TARGACEPT INC0000899243-15-002335
SEC(opens sec.gov)
Mar 204
Biodel Inc0001145443-15-000410
SEC(opens sec.gov)
Feb 175
CLEVELAND BIOLABS INC0001209191-15-014845
SEC(opens sec.gov)
Jan 124
CLEVELAND BIOLABS INC0001209191-15-003673
SEC(opens sec.gov)
Dec 124
TARGACEPT INC0001181431-14-038781
SEC(opens sec.gov)
Mar 64
Biodel Inc0001145443-14-000303
SEC(opens sec.gov)
Jun 214
CLEVELAND BIOLABS INC0001171843-13-002569
SEC(opens sec.gov)
Jun 184
CLEVELAND BIOLABS INC0001171843-13-002529
SEC(opens sec.gov)
Jun 104
TARGACEPT INC0001140361-13-024689
SEC(opens sec.gov)
May 134
BROWN JULIA R0001140361-13-020356
SEC(opens sec.gov)

Companies

Address

C/O TARGACEPT, INC. 200 EAST FIRST STREET, SUITE 300

WINSTON-SALEM, NC, 27101